Trials / Sponsors / Shanghai GeneChem Co., Ltd.
Shanghai GeneChem Co., Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) Carcinoma, Hepatocellular | Phase 1 / Phase 2 | 2017-04-01 |
| Unknown | A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus (SLE) | Phase 1 | 2017-03-01 |
| Unknown | A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy Carcinoma, Hepatocellular, Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic | Phase 1 / Phase 2 | 2016-07-01 |
| Unknown | A Study of GPC3 Redirected Autologous T Cells for Advanced HCC Carcinoma, Hepatocellular | Phase 1 / Phase 2 | 2016-03-01 |
| Unknown | A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma Pancreatic Cancer | Phase 1 | 2016-03-01 |
| Unknown | A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leu Leukemia, B-Cell | Phase 1 / Phase 2 | 2016-01-01 |